Du Hao-Yue, Cao Dan-Ni, Chen Ying, Wang Lv, Wu Ning, Li Jin
State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Beijing 100850, China.
State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Beijing 100850, China.
Neurosci Lett. 2016 Jan 12;611:21-7. doi: 10.1016/j.neulet.2015.11.016. Epub 2015 Dec 1.
Drug addiction is a process that transits from recreative and regular drug use into compulsive drug use. The two patterns of drug use, controlled drug intake and escalated drug intake, represent different stages in the development of drug addiction; and escalation of drug use is a hallmark of addiction. Accumulating studies indicate that microRNAs (miRNAs) play key regulatory roles in drug addiction. However, the molecular adaptations in escalation of drug use, as well as the difference in the adaptations between escalated and controlled drug use, remain unclear. In the present study, 28 altered miRNAs in the prefrontal cortex (PFC) were found in the groups of controlled methamphetamine self-administration (1h/session) and escalated self-administration (6h/session), and some of them were validated. Compared with saline control group, miR-186 was verified to be up-regulated while miR-195 and miR-329 were down-regulated in the rats with controlled methamphetamine use. In the rats with escalated drug use, miR-127, miR-186, miR-222 and miR-24 were verified to be up-regulated while miR-329 was down-regulated compared with controls. Furthermore, bioinformatic analysis indicated that the predicted targets of these verified miRNAs involved in the processes of neuronal apoptosis and synaptic plasticity. However, the putative regulated molecules may be different between controlled and escalated drug use groups. Taken together, we detected the altered miRNAs in rat PFC under the conditions of controlled methamphetamine use and escalated use respectively, which may extend our understanding of the molecular adaptations underlying the transition from controlled drug use to addiction.
药物成瘾是一个从消遣性和规律性用药转变为强迫性用药的过程。两种用药模式,即受控药物摄入和递增药物摄入,代表了药物成瘾发展的不同阶段;而药物使用的递增是成瘾的一个标志。越来越多的研究表明,微小RNA(miRNA)在药物成瘾中起关键调节作用。然而,药物使用递增过程中的分子适应性变化,以及递增用药和受控用药之间适应性变化的差异,仍不清楚。在本研究中,在受控甲基苯丙胺自我给药组(1小时/次)和递增自我给药组(6小时/次)的前额叶皮质(PFC)中发现了28种改变的miRNA,其中一些得到了验证。与生理盐水对照组相比,在受控使用甲基苯丙胺的大鼠中,miR-186被证实上调,而miR-195和miR-329下调。在递增用药的大鼠中,与对照组相比,miR-127、miR-186、miR-222和miR-24被证实上调,而miR-329下调。此外,生物信息学分析表明,这些已验证miRNA的预测靶点参与神经元凋亡和突触可塑性过程。然而,受控用药组和递增用药组之间推定的调控分子可能不同。综上所述,我们分别在受控使用甲基苯丙胺和递增使用甲基苯丙胺的条件下检测了大鼠PFC中改变的miRNA,这可能会扩展我们对从受控用药到成瘾转变背后分子适应性的理解。